Development and Validation of a Survival Machine Learning Model for Predicting Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in Patients With Coronary Artery Aneurysm or Ectasia
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background Patients with coronary artery aneurysm or ectasia (CAAE) remain at risk of major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI). We aimed to develop and temporally validate a model for post-discharge MACE. Methods This single-centre retrospective cohort included 574 adults with angiographically confirmed CAAE who underwent PCI and survived to discharge. Patients were chronologically assigned to development (n = 456) and temporal validation (n = 118) cohorts. Missing data were handled using five MICE datasets. LASSO-Cox selected predictors, and six survival algorithms were compared using 10 repeats of stratified five-fold cross-validation. Internal validation used 1,000 patient-level bootstrap resamples with optimism correction; temporal validation was performed without refitting or recalibration. Results During follow-up, 85 development-cohort patients and 12 temporal-validation patients experienced MACE, including 45 and 11 patients, respectively, within 3 years. Seven predictors were retained. Random survival forest (RSF) was selected according to the prespecified rule, with the highest mean out-of-fold C-index (0.761, SD 0.038). In development, the optimism-corrected C-index and 3-year AUC were 0.813 (95% CI 0.782–0.838) and 0.847 (0.806–0.881); corresponding temporal validation estimates were 0.826 (0.734–0.910) and 0.843 (0.742–0.931). Compared with Cox, RSF improved 3-year AUC by 0.098 in development (P = 0.018) and 0.118 in temporal validation (P = 0.032). Conclusions RSF showed good discrimination and identified a high-risk group, with preliminary support from same-centre temporal validation. Calibration and clinical net benefit require confirmation in larger, multicentre cohorts before clinical use.
Source: Research Square
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G4469558722, G7634886089, G9001342787
OpenAlex ID: W7236492335
